IIL unveils diversification plans
Indian Immunologicals Ltd (IIL) is embarking on an ambitious diversification programme and has set up five new vaccine production facilities to produce diptheria, pertusses, tetanus, measles and recombinant hepatitis B vaccine
PharmaNet opens India office in Bangalore
PharmaNet, an international drug development company based in New Jersey opened its office in India in Bangalore with the appointment of Dr Suresh Bowalekar as Senior Director – Biostatistics and Data Management and Rajendra Talele as Manager of Clinical Research.
Lupin: Good outlook reflected by great 2Q interims, clean-up exercise
Lupin, which posted a 97 per cent decline in net profits this September quarter compared to the previous, will have its earnings growth in the next half a decade driven by its recent product approvals, analysts here said.
AT A GLANCE